Background: Physical therapy has not been evaluated much for the treatment of chronic venous insuffi ciency before. Th e question is whether balneohydrotherapy and usual care combined is superior to usual care alone.
Introduction
Lower limb chronic venous insufficiency (CVI) is a major public health problem, with which 18 million of the French population is aff ected. Between 11 % and 24 % of inhabitants in the industrialized countries suff er from CVI with a female preponderance [1] . Its prevalence increases with age. It was estimated that CVI suff erers were accountable for approximately 1 -2 % of the health care budget of European countries [2] . Various treatment methods are available with good clinical results at midterm, but also with a high frequency of recurrence. Venoactive drugs, compression therapy using bandages and compression stocking are recommended [3] , but the adherence to treatment is not always optimal, especially in summer. Correction of venous refl ux by open surgery or endovenous procedures including ultrasound-guided foam sclerotherapy are also recommended [3] . Only little is known about the eff ect of physical therapy.
Balneohydrotherapy (also called crenobalneotherapy, balneotherapy, spa therapy or crenotherapy) is a traditional therapeutic procedure in Europe, North Africa, South America, Middle East and Japan and is sometimes used for the treatment of CVI. In France, the treatment of chronic venous disorders represents 80,000 of the 500,000 patients treated each year in spa centers. Balneohydrotherapy is delivered in a three weeks course and is reimbursed by the French national health insurance system (Caisse Nationale d' Assurance Maladie). It combines many procedures using mineral water; wandering in the pool restores the muscle pump, and the hydrostatic pressure decreases the edema, underwater massages and Kneipp technique (alternate hot and cold showers) stimulate the cutaneous vasomotor response and underwater exercises improve the aggravating locomotor factors (knee, ankle ankylosis, etc.). Th is study evaluates the eff ect of balneohydrotherapy on the quality of life in patients with CVI.
Patients and methods
Patients were recruited locally so that they could attend the spa center on a daily basis. Announcements for the recruitment were performed mainly by advertisements in the regional press and also by posters in pharmacies and the waiting room of the specialists [5] . Th ey referred to treatment for CVI, but did not specify the spa therapy. Inclusion criteria were: patients 18 to 80 years old and diagnosed with CVI stage 3 or 4 according to the CEAP classifi cation regardless of etiology [4] . Patients were included if they accepted to participate in a 3 week treatment in the spa center and to be followed-up for 6 months. Exclusion criteria were: pregnant women, contra-indication for the spa treatment (chronic infectious diseases, cancer, heart failure, serious liver or kidney disease, open leg ulcer, psychiatric disorders, immune defi ciency, phlebitis, erysipelas or history of erysipelas); planned surgery in the next 3 months, spa treatment in the previous 6 months, and professional involvement in the spa center. All patients were evaluated by the same practitioner at the beginning of the trial and during the follow-up. Th is independent practitioner was a senior specialist for CVI, who had no connection with the spa center. Th e study took place in Aix-Les-Bains spa center (Th ermes Nationaux d' AixLes-Bains) which is the third most important spa center in France, delivering service to 30,000 patients/year. All participants signed an informed consent form. At the beginning of treatment, patients were advised to continue their usual medications and to use compression therapy. A booklet with advice on lifestyle was also delivered. Th ere where no specifi c requirements for the usual care. Treatment was prescribed by the spa doctors working in private outpatient clinics. Patients were examined 3 times; just prior to the Commencement of treatment, in the middle of the 3 week period and at the end of the treatment. During the consultations, adherence to the treatment schedule was controlled and side effects were recorded. Th e treatment group received 18 days of balneohydrotherapy in three weeks. Th e treatment comprised 4 diff erent spa techniques daily: Kneipp therapy, walking the pool, underwater massage and a bath in a tub. Aft er termination of the daily programme, patients would rest 20 minutes in the Trendelenburg position. Kneipp therapy is an alternating warm (28 °C) and cold (14 °C) shower on the legs of 10 minutes duration. Th e walking pool is 60 cm deep with an underwater shower jet at 23 °C and patients walking in it for 10 minutes without stopping. Underwater massage is performed under a 38 °C shower by a senior physiotherapist, beginning at the feet and gradually proceding to the thighs, lasting 10 minutes. Th e bath tub contains a underwater shower at 30 °C, which also works from the feet and gradually to the thighs over a period of 20 minutes. For each treatment modality, mineral water alone was used as it is an obligation for French spa centers. All interventions were standardized by timers. Adherence to each technique was supervised during each session as is the practice for all patients treated in the spa center. Th ese modalities are defi ned for all the spa centers in France by negotiation with the health insurance system. Aft er admission to the programme, patients were sent to one of the spa practitioners. Th ey were examined at the beginning, in the middle and at the end of the treatment period, as is customary in France. Body weight, heart frequency and blood pressure were systematically measured. Th e same balneohydrotherapy program was proposed to the control group at the end of the study period (three months later). Th e hypothesis was that aft er three months balneohydrotherapy would be superior to being on a waiting list for patients with CVI, as measured by self-assessment questionnaires. Th ese were completed by the patients without the presence of the examining physician, and aft er the consultation in order to limit his infl uence on the answers. Primary outcome was a 20 % improvement in quality of life aft er three months. Quality of life was measured by a French validated version of the Chronic Venous Insuffi ciency Questionnaire (CIVIQ 2) [6] . Secondary outcomes were based on the Rutherford severity score, CIVIQ2, change in associated treat-ment, patient acceptable symptom state (PASS), opinion of patient and practitioner, side eff ects. Rutherford severity score is a clinical evaluation of disease severity taking into account 10 attributes: pain, varicose veins, venous edema, skin pigmentation, and adherence to compressive therapy, infl ammation, induration, number, size and duration of active ulcer. Each attribute is scored from 0 (minimum) to 2 (maximum). [7] CIVIQ yields a disease-specifi c QOL (quality of life) score for patients with CVI. Th e total score is derived from 20 questions (items) that represent four QOL dimensions (of 3 -9 items each): bodily pain, physical, social and psychological functioning. Th e possible scores for each item are as follows: 1, negative; 2, weak; 3, moderate; 4, strong; 5, severe. Th e total scores can therefore vary from 20 (no symptoms) to 100 (worse possible condition). PASS is measured by asking the patient if he/she feels he/she is in an acceptable clinical condition in terms of his/her venous insuffi ciency. Th e opinion of the patient and the practitioner is determined on a 5 point Likert's scale (very aggravated, aggravated, unchanged, improved and very improved). Drug consumption is estimated for the last 3 days prior to the evaluation. Surgery, hospitalization for venous insuffi ciency and adherence to compression therapy were also evaluated. On the basis of the only published study [8] and previous unpublished studies in our spa center, we estimated that 50 % of patient in the treatment group and 30 % of patients in the control group would have a 20 % clinical improvement. Th e alpha risk was chosen at 5 % and the beta risk at 20 % (for an 80 % statistical power). Th e number of patients to include, calculated by the Casagrande and Picke methods was 72 patients per group (totally 144 patients).
A block randomization was generated by one of the authors (RF). It was carried out with block sizes of 6, 8 and 10 patients with a random order which was determined by dice rolls. Every block comprised 50 % treatment and 50 % control, respectively. Concealed allocation was performed by the same author who was not in contact with the participants of the study. Assignment was given by telephone to the examining physician (JMM) who informed the patients. Blinding was not possible to achieve for patients, as is the case in most nonpharmacological trials [9] . It was also diffi cult to achieve for the examining physician because he was informing the patients about the assignment. He was blinded to the previous answers of the patients. Blinding was not possible for the spa physicians because they were prescribing the treatment and collecting the side eff ects. It was not possible for the care providers since the spa center only treats patients with rheumatic diseases and treatments modalities are diff erent. Blinding could only be realized by the statistician. Th e fi rst author (RF) carried out the randomization; he performed the data entry, the data monitoring and froze the database. Th en he masked the group assignment with a code. Statistical analysis was performed by the third author (AF) who was unaware of the treatment group.
Statistical analysis
Statistical analysis was performed as planned in the protocol accepted by the ethics committee. It was based on an intention to treat method. Categorical variables were expressed as frequency and percentage, continuous variables as mean and standard deviation (SD). Th e main endpoint was tested using an uncorrected χ 2 test. Risk ratios were reported with 95 % confi dence interval (CI), and eff ect size with 95 % CI. Secondary qualitative endpoints were analyzed using the same principles. For between-group comparisons at the fi rst and third month the MannWhitney test was used. Two-sided p values less than 0.05 were considered statistically signifi cant for the main criteria. Since we performed 10 statistical tests for the secondary criteria, 
Results
Patients were recruited in the period from July 2010 to February 2012. Th e last patient was evaluated in May 2012. 99 patients were randomized and 94 were analyzed for the main criteria (Figure 1) . Th e two groups were similar at baseline (Table I) .
Primary outcome
Th e number of patients in each group with 20 % improvement in CIVIQ2 is shown in Table II Table III : Th ere is a greater improvement in quality of life CIVIQ (ES: 0.18 vs. 1.07), the Rutherford scale (ES: 0.03 vs. 1.31), the opinion of patient and the opinion of the examining physician following the study for the balneohydrotherapy group. Th e CEAP classifi cation is reported in table IV; there is no diff erence between groups. We didn't observe any serious side eff ect in either groups. One patient in the control group died of diff use bleeding before starting the treatment, one case of superfi cial thrombosis occurred in the balneohydrotherapy group (considered as a failure of treatment). One erysipela was seen in the control group in the third week and one in the treatment group in the third month.
Discussion
Th is study shows that balneohydrotherapy plus usual care may provide a signifi cant improvement of the quality of life of patients when compared Venoactive drug intake (n) 9 9
Usage of compression stockings (n) 26 30
History of spa treatment for veins(n) 7 7
History of spa treatment for rheumatism(n) 17 18 History of surgery for veins (n) 27 28
Previous erysipelas (n) 1 2
Deviations in protocol (n) One of the strengths of our study lies in the choice of the primary endpoint. We believe it is relevant for the patient. We note that it is supported by the patient's and the practitioner's opinions. Th e choice of a qualitative criterion is considered likely to cancel the placebo eff ect [11] and also the effect of the lack of assessment blinding [12] for diseases with mainly functional symptoms such as CVI. Maybe a three month follow up is too short for three weeks of treatment. We had chosen this period to limit the lost to follow up and also for the ethical reason that the control group was not off ered any additional treatment. It does not mean that the treatment effect cannot last longer. Th e selection procedure recruited nearly 50 % of the patients that were examined, this off ered a good chance to have a representative population of patients with CVI. Th is important point is not usually observed (and sometimes not reported) in other studies. Previous studies on balneotherapy are sometimes unclear regarding the population in which recruitment was made. It is well known that in pharmacologic trials patients that are included in the study are not always representative of the population to which treatment will be off ered (less than 5 % in a study of antidepressants). [13] Due to the inability to obtain a blinding of patients, it is also diffi cult to obtain a true blinding of the examining physician and caregivers and it may overestimate the treatment eff ect. We chose to use a self-completed questionnaire, fi lled out in the absence Th ird week 8,9 +/-3.5 6,3 +/-3.0 < ,0001
Th ird month 8,7 +/-2.9 5,7 +/-3.0 < ,0001
Number of improved patients (self-assessment)
Th ird week OR = 68. of the medical examiner, in order to preserve the independence of the patients. Th e medical examiner is an independent doctor who never had activity in connection with the spas, so as to achieve maximum objectivity in the assessment of patients. Th e lack of blinding of patients is known to promote the "placebo" eff ect. In this study, this eff ect is minimized by utilization of the same follow-up method for both groups [14] and the use of a qualitative endpoint as we mentioned before. It remains, however, that the lack of blinding of patients could overestimate the treatment eff ect. [15] Th e severity of the recruitment criteria led us to interrupt it at 99 while 174 patients were expected in the protocol. On the other hand, the improvement of patients in the treatment group had been higher than the estimations we made to calculate the number of subjects needed. It was suffi cient to observe a signifi cant difference between the groups. Waiting list method may overestimate the difference between groups by deception bias in the control group. It should be noted that this bias was probably of limited infl uence in our study since the control group improved, although insignifi cantly, while it remained stable [16] or worse [8] in previous studies using similar methodology. We observed that the proportion of patients using compression therapy was high at the beginning and low during follow up. We think that it did not infl uence the results since the proportion of patients remained similar in both groups. We gave the same questionnaires at the entry and during the follow up. It is possible that the patients might have understood the question about compression in a diff erent way for each evaluation. Maybe, they answered "if they had ever used compression?" at fi rst questioning, and "if they have used a contention recently?" for the follow up. Th ere is a possible lack of observance in the treatment. Unfortunately, we didn't evaluate observance but it was systematically collected by the supervisors of the spa center, as is usually done for all the patients treated. For the ordinary patients, observance rate in the spa center is 95 to 100 % (personal data). If it had been the case for our study, this would have underestimated the treatment eff ect. Two similar studies have already been published in the same fi eld by Carpentier et al. [8, 17] . In the fi rst one, the primary endpoint was a measure of malleolar chromametry which has the advantage of being an objective measurement, but its clinical relevance to the patient is not known. Th e study compared a spa group and therapeutic education with a waiting list of patients who continued their usual treatment in the expectation of a cure at the end of the study, as in our work. It showed a signifi cant improvement for the treatment group. Other endpoints were the same as those of our tests and improved with the same proportions. Th e number of patients is slightly higher in our study (99 vs. 63) and CIVIQ scale goes from 52.5 to 47 at the 3 rd month in comparison to 55.5 to 40.3 in our study. On the other hand this study combined spa treatments and therapeutic education sessions that probably reinforced the eff ect of thermal treatment. Th e second is a large randomized trial also comparing balneotherapy plus patient education with waiting list patients [16] . Th e main criterion was not statistically diff erent (incidence of ulcers), but the clinical improvement of CIVIC decreased from 38 to 33 at six months. Th e clinical status of the patients was more severe at the entry (CEAP 4 to 5 as opposed to 3 to 5 in our study). Th e control group had balneotherapy plus education one year later which might have caused a deception bias and overestimation of treatment eff ect regarding continuous subjective criteria [11] . Previous studies have been published on Kneipp therapy [18] and balneokinesis [19] , but they did not choose a main criterion and did not perform intent-to-treat (ITT) analysis.
Conclusions
With some methodological limitations, this study shows an improvement of clinical status and quality of life of patients with CVI treated with balneohydrotherapy when compared with usual care and treatment and is well tolerated. Balneohydrotherapy can be proposed as a treatment option for patients with CVI, especially for those who have diffi culties with the adherence to compression stockings or those for whom there is no surgical solution. 
